Related Experiment Video
Updated: Jun 18, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Hepatobiliary associations with inflammatory bowel disease.
Crystal Knight1, Karen F Murray
1Seattle Children's and University of Washington School of Medicine, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, 4800 Sand Point Way, NE, PO Box 5371/W-7830, Seattle, WA 98105, USA. crystal.knight@seattlechildrens.org
Expert Review of Gastroenterology & Hepatology
|November 26, 2009
Summary
Inflammatory bowel disease (IBD) patients frequently experience liver issues, including primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). Medications for IBD can also harm the liver.
Area of Science:
- Hepatology
- Gastroenterology
- Immunology
Background:
- Hepatobiliary diseases are prevalent in patients diagnosed with inflammatory bowel disease (IBD).
- Key autoimmune liver conditions associated with IBD include primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH).
- Immunosuppressive therapies used for IBD management carry a risk of drug-induced liver injury (hepatotoxicity).
Purpose of the Study:
- To review the spectrum of liver disease associations in patients with IBD.
- To discuss primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), and overlap syndromes in the context of IBD.
- To examine drug-related hepatotoxicities commonly encountered during IBD treatment.
Main Methods:
- Literature review of hepatobiliary manifestations in IBD.
- Analysis of epidemiological data on liver diseases in IBD cohorts.
- Review of pharmacological data on IBD medications and their hepatotoxic potential.
Main Results:
- Primary sclerosing cholangitis (PSC) shows the strongest association with IBD, particularly ulcerative colitis.
- Autoimmune hepatitis (AIH) is less frequently linked to IBD compared to PSC.
- Overlap syndromes, combining features of PSC and AIH, are also observed in some IBD patients.
Conclusions:
- IBD patients have a significant risk of developing specific autoimmune liver diseases, primarily PSC.
- Awareness of potential drug-induced liver injury from IBD medications is crucial for patient management.
- Comprehensive evaluation for hepatobiliary complications is essential in the care of individuals with IBD.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...